Market Overview

Morning Market Movers

Share:
Related ALNY
Credit Suisse Bullish On Most Big Pharma Names
Alnylam Pharmaceuticals Dips Lower After Company Announces 2016 Pipeline Goals Towards 'Alnylam 2020'
Alnylam Pharmaceuticals' (ALNY) CEO John Maraganore on Q4 2015 Results - Earnings Call Transcript (Seeking Alpha)
Related MRK
ALK Announces Merck Submits BLA to FDA for Investigational House Dust Mite SLIT-tablet
How To Invest In An Aging World With The 'Live Long & Prosper' ETF
Intercept Pharma Spikes On Report That It's Exploring A Sale (Investor's Business Daily)

Alnylam Pharmaceuticals (NASDAQ: ALNY) rose 34.16% to $88.83 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

Rexahn Pharmaceuticals (NYSE: RNN) jumped 33.77% to $1.53. Rexahn Pharmaceuticals shares have jumped 235.29% over the past 52 weeks, while the S&P 500 index has gained 25.27% in the same period.

Rosetta Genomics (NASDAQ: ROSG) moved up 33.23% to $4.25 after the company reported that it has signed a master service provider agreement with a major global biopharmaceutical company.

Teche Holding Company (NYSE: TSH) shares jumped 28.44% to $70.00 after IBERIABANK (NASDAQ: IBKC) announced an agreement to acquire Teche Holding.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (ALNY + IBKC)

View Comments and Join the Discussion!

Get Benzinga's Newsletters